Abbott Laboratories (ABT) Gross Profit (2009 - 2026)

Abbott Laboratories has disclosed Gross Profit across 18 years of filings, most recently posting $7.3 billion for Q2 2026.

• In Q2 2026, Gross Profit rose 15.59% year-over-year to $7.3 billion; the TTM figure through Jun 2026 stood at $26.4 billion (up 9.22% YoY), while the FY2025 annual figure was $25.0 billion, up 7.59% from the prior year.
• Gross Profit came in at $7.3 billion for Q2 2026 at Abbott Laboratories, up from $6.3 billion in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $7.3 billion in Q2 2026 to a low of $5.4 billion in Q1 2023.
• Average Gross Profit over 5 years is $6.0 billion, with a median of $5.9 billion recorded in 2024.
• Year-over-year, Gross Profit grew 19.86% in 2022 and dropped 21.6% in 2023.
• Over 5 years, Gross Profit stood at $5.5 billion in 2022, then gained by 3.4% to $5.7 billion in 2023, then increased by 6.1% to $6.0 billion in 2024, then climbed by 8.37% to $6.5 billion in 2025, then grew by 11.18% to $7.3 billion in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $7.3 billion in Q2 2026, $6.3 billion in Q1 2026, and $6.5 billion in Q4 2025.